Evexia Q4FY26: Profit Rises, Audit Qualified

5 min read     Updated on 15 May 2026, 04:15 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Evexia Lifecare Limited reported a rise in net profit for the financial year ended March 31, 2026, with standalone profit reaching ₹152.10 Lakhs and consolidated profit at ₹162.13 Lakhs. The company's board approved the audited results on May 09, 2026, and published advertisements in the Financial Express on May 14, 2026. However, the statutory auditor issued a qualified report citing significant concerns regarding loan and trade receivables, fair valuation of investments, and the going concern status of a subsidiary. Additionally, the company extended the redemption period for its Foreign Currency Convertible Bonds to February 3, 2028.

powered bylight_fuzz_icon
39610778

*this image is generated using AI for illustrative purposes only.

Evexia Lifecare Limited held its Board of Directors meeting on May 09, 2026, and approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The company disclosed that advertisements for these results were published in the Financial Express (English and Gujarati) on May 14, 2026, with a corrigendum published on May 15, 2026. The results were audited by Tejas K. Soni and Company, Chartered Accountants, who issued a qualified audit report on both standalone and consolidated financial statements.

Standalone Financial Performance

On a standalone basis, the company reported revenue from operations of ₹10,546.47 Lakhs for the full year, compared to ₹8,388.68 Lakhs in the previous year. Total revenue, including other income, stood at ₹10,635.03 Lakhs against ₹8,402.33 Lakhs. Net profit for the year rose to ₹152.10 Lakhs from ₹72.79 Lakhs. The following table presents the key standalone financial metrics:

Metric: Q4 FY26 (Audited) Q3 FY26 (Unaudited) Q4 FY25 (Audited) FY26 (Audited) FY25 (Audited)
Revenue from Operations (₹ Lakhs): 3,517.94 2,455.92 1,517.93 10,546.47 8,388.68
Other Income (₹ Lakhs): 54.63 25.96 3.41 88.56 13.65
Total Revenue (₹ Lakhs): 3,572.57 2,481.88 1,521.34 10,635.03 8,402.33
Total Expenses (₹ Lakhs): 3,518.03 2,430.84 1,469.26 10,429.48 8,281.95
Profit Before Tax (₹ Lakhs): 56.54 55.04 32.08 205.55 120.38
Net Profit (₹ Lakhs): 46.96 40.73 18.16 152.10 72.79
Basic EPS (₹): 0.003 0.002 0.001 0.008 0.004
Diluted EPS (₹): 0.003 0.002 0.001 0.008 0.004

Consolidated Financial Performance

On a consolidated basis, the company reported revenue from operations of ₹11,027.50 Lakhs for the full year against ₹8,659.04 Lakhs in the prior year. Total consolidated revenue stood at ₹11,027.53 Lakhs. Consolidated net profit for the year was ₹162.13 Lakhs compared to ₹41.25 Lakhs in the previous year. Profit attributable to owners of the parent stood at ₹158.88 Lakhs for the year. The key consolidated financial metrics are summarised below:

Metric: Q4 FY26 (Audited) Q3 FY26 (Unaudited) Q4 FY25 (Audited) FY26 (Audited) FY25 (Audited)
Revenue from Operations (₹ Lakhs): 3,678.84 2,524.38 2,361.19 11,027.50 8,659.04
Total Revenue (₹ Lakhs): 3,688.51 2,550.34 2,361.19 11,027.53 8,673.11
Total Expenses (₹ Lakhs): 3,598.73 2,510.89 2,316.88 10,607.70 8,881.26
Profit Before Tax (₹ Lakhs): 89.79 39.45 44.31 219.85 91.86
Net Profit (₹ Lakhs): 77.85 29.19 30.89 162.13 41.25
Profit Attributable to Owners (₹ Lakhs): 74.60 29.19 30.89 158.88 41.25
Basic EPS (₹): 0.004 0.002 0.003 0.008 0.002
Diluted EPS (₹): 0.004 0.002 0.002 0.008 0.002

Audit Qualifications and Key Concerns

The statutory auditor issued a qualified opinion on both standalone and consolidated financial results. Key qualifications include: loan receivables of ₹735.13 Lakhs with significant credit risk for which no expected credit loss assessment has been made; trade receivables of ₹2,943.89 Lakhs similarly lacking an expected credit loss assessment; investments in unquoted equity shares of ₹87.39 Lakhs for which fair valuation cannot be determined; and exposure of ₹127.70 Lakhs in subsidiary Kavit Edible Oil Limited, which has suspended manufacturing operations since March 2019 and carries a negative net worth, raising going concern doubts. The auditors also noted material misstatements, non-compliance with financial reporting frameworks, and inability to verify significant transactions due to lack of audit evidence. The management's impact assessment for all qualifications was stated as not ascertainable, and the qualifications are repetitive in nature.

FCCB Extension and Other Notes

During the year, the company entered into an arrangement with Foreign Currency Convertible Bond (FCCB) holders to extend the conversion/redemption period from March 2, 2026 to February 3, 2028, subject to applicable regulatory requirements. The management has evaluated the accounting impact of this extension and believes it does not have any material adverse impact on the financial statements.

Historical Stock Returns for Evexia Lifecar

1 Day5 Days1 Month6 Months1 Year5 Years
+4.38%+30.00%+104.29%-14.88%-47.23%-88.85%

Will Evexia Lifecare's repetitive audit qualifications—particularly the absence of expected credit loss assessments on ₹3,679 Lakhs in receivables—trigger regulatory scrutiny from SEBI or stock exchanges, and what timeline might the company face to remediate these concerns?

Given that subsidiary Kavit Edible Oil Limited has suspended operations since March 2019 with negative net worth, what are the likely options management will pursue—revival, divestiture, or liquidation—and how could each scenario impact Evexia's consolidated balance sheet?

With six unaudited subsidiaries holding ₹71,543 Lakhs in total assets representing a significant portion of the consolidated balance sheet, what risks does this audit gap pose to investor confidence and future fundraising or credit access for the company?

Evexia Lifecare Limited Appoints M/s. Tejas K. Soni and Company as Statutory Auditor for FY 2025-26

1 min read     Updated on 17 Apr 2026, 03:58 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Evexia Lifecare Limited has appointed M/s. Tejas K. Soni and Company, Chartered Accountants (FRN: 135093W) as its statutory auditor for FY 2025-26 to fill a casual vacancy. The Board approved the appointment on February 17, 2026, though disclosure was delayed due to administrative oversight. The Vadodara-based auditing firm is peer-reviewed by ICAI and maintains no association with company directors.

powered bylight_fuzz_icon
37967336

*this image is generated using AI for illustrative purposes only.

Evexia Lifecare Limited has appointed M/s. Tejas K. Soni and Company, Chartered Accountants as its new statutory auditor to fill a casual vacancy for the financial year 2025-26. The appointment comes following the resignation of the company's previous statutory auditor.

Board Approval and Appointment Details

The Board of Directors of evexia lifecar approved the appointment during its meeting held on February 17, 2026 at the company's registered office. The newly appointed auditing firm, M/s. Tejas K. Soni and Company, carries the Firm Registration Number (FRN) 135093W.

Parameter: Details
Auditor Name: M/s. Tejas K. Soni and Company, Chartered Accountants
FRN: 135093W
Appointment Date: February 17, 2026
Term: F.Y. 2025-26
Reason: Fill casual vacancy due to previous auditor's resignation

Delayed Disclosure and Compliance

The company has acknowledged a delay in submitting the mandatory disclosure regarding the auditor appointment. According to the filing dated April 17, 2026, the delay occurred due to administrative oversight and was described as purely inadvertent and unintentional. Evexia Lifecare has expressed regret for the delay and assured stakeholders that necessary steps have been taken to strengthen internal compliance mechanisms to prevent such delays in the future.

Auditor Profile and Credentials

M/s. Tejas K. Soni and Company is described as a prominent chartered accountancy firm based in Vadodara. The firm maintains high standards of professional integrity and is committed to excellence and ethical values in all aspects of its operations. Notably, the firm has been peer reviewed by the Peer Review Board of ICAI, New Delhi, holding certificate number 018005 dated August 30, 2024.

Regulatory Compliance

The appointment disclosure has been made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has confirmed that there is no association between the newly appointed auditor and any of the company's directors, ensuring independence in the auditing process.

The appointment is specifically for the financial year 2025-26 and is intended to fill the casual vacancy that arose due to the resignation of the previous statutory auditor.

Historical Stock Returns for Evexia Lifecar

1 Day5 Days1 Month6 Months1 Year5 Years
+4.38%+30.00%+104.29%-14.88%-47.23%-88.85%

What factors led to the previous statutory auditor's resignation and could similar issues affect future auditor retention?

Will the delayed disclosure trigger any regulatory penalties or impact Evexia Lifecare's compliance rating with SEBI?

How might the auditor change affect investor confidence and the company's stock performance in the coming quarters?

More News on Evexia Lifecar

1 Year Returns:-47.23%